Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUT RESTORE-PAH: Microbiota Transplant in Pulmonary Arterial Hypertension
NCT06481852Phase 1Recruiting
- Sponsor
- University of Minnesota
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised trial in pulmonary arterial hypertension (PAH) (3 arms), sponsored by University of Minnesota. Primary endpoint: Donor engraftment comparison at 12 weeks. Started Oct 2024; status: recruiting.
02
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT06481852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06481852.